Its combined pro-angiogenic, cytoprotective, and anti-inflammatory properties make BPC-157 a promising research peptide for studies in regenerative medicine, vascular biology, and injury recovery
(Jr.) (1987)
Direct stimulation of -cell D2R and D3R with dopamine (DA) or D2R/D3R agonists inhibits glucose-stimulated insulin secretion (GSIS) in both human and mouse pancreatic islets 6,7,8,10 , suggesting that -cell D2R/D3R signaling is an important regulator of GSIS 5,6,8,9
So, where does WADA stand on BPC-157
T., & Chow, B
doi.org/10.2174/1381612824666180712110447 Bock-Marquette, I., et al